COVID-19 and Rhino-orbital Mucormycosis

Detect the clinical presentation and outcome of post covid-19 fungal mucormycosis in patients referred to Minia university Hospital.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Mucormycosis Bacterial Infections and Mycoses Infections Mycoses Zygomycosis

Sex eligibility

All sexes

Study type

Observational

Primary location

Faculty of Medicine- Minia University

Minya, 61111, Egypt

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients who had positive PCR test for Covid-19.
Fungal rhino-orbital infection was confirmed.

Exclusion criteria

Suspected patient with COVID-19 not confirmed with PCR
Incomplete data

Treatment and study plan

Primary outcomes

Outcome of rhino-orbital mucormycosis in COVID-19 patients

Time frame: 9 months

Data of the patients who had post Covid-19 fungal mucormycosis in the last year will be revised to detect clinical presentation and final outcome

Sponsors and collaborators

Lead sponsor

Minia University

Other

Registry information

Official study title

Clinical Profile and Outcome of Post Covid-19 Rhino-orbital Fungal Mucormycosis in Minia Governorate

Important dates

Study start: 2021
Primary completion: 2023
Study completion: 2023
First posted: Jan 28, 2022
Registry last updated: Oct 18, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed